Browse the full record of transactions filed by 김은석, Chief Executive Officer. Director active across 1 companies, notably 대화제약. Cumulatively, 5 disclosures have been recorded. The latest transaction was disclosed on 27 April 2026 — Purchase. Regulator: DART (FSS). The full history is openly available.
Kim Eun-seok is the CEO of 대화제약. He leads the company and is responsible for overall strategy and operations management. His leadership is essential for the development and growth of 대화제약 in the market.